Tissue-Based Testing News on immunohistochemistry and other tissue-based testing methods. ChromaCode Initiates Strategic Shift to Oncology With New Leadership, Digital PCR Lung Cancer Test Premium Multiplexed PCR specialist ChromaCode has hired a new CEO and chief business officer to help spearhead its transition to the oncology testing space. Lunaphore Raises CHF 40M in Series D Financing The funding for the protein detection and spatial biology company includes a €10 million ($10.9 million) venture debt facility from Norgine Ventures. RareCyte Moving Into Higher-Plex Spatial Proteomics Premium The firm believes its Orion system's combination of multiplexing, data quality, and throughput will help it carve out a space in an increasingly crowded market. AGBT: NanoString, 10x Genomics Plan High-Resolution Spatial Assays to Detect Thousands of RNAs At last week's meeting, the firms shared their respective work on developing assays to detect 6,000 RNAs on the CosMx platform and 5,000 RNAs on the Xenium instrument. Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics. Dec 14, 2022 Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round Sep 28, 2022 Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium Aug 25, 2022 Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval Jul 6, 2022 Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition Jun 3, 2022 Swiss Immunohistochemistry Firm Lunaphore Shifts Focus to High-Plex Spatial Proteomics Premium Jun 3, 2022 Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial Jun 1, 2022 Max Planck Team Develops Workflow Combining Single-Cell Imaging With Deep Proteomic Profiling Premium May 11, 2022 Thermo Fisher Scientific Invests in Spatial Proteomics Firm Ionpath Mar 22, 2022 Precision Medicine Firm PreludeDx Closes $20M Funding Round Mar 8, 2022 Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test Sep 9, 2021 RareCyte Secures $24M to Advance Spatial Biology Platform, Expand Globally Jun 22, 2021 Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product Premium Mar 9, 2021 Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients Mar 2, 2021 PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium Jan 19, 2021 Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores Dec 10, 2020 Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round Nov 18, 2020 Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies Sep 22, 2020 Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug Aug 21, 2020 Owkin Machine Learning Infers RNA Expression From Tissue Images in New Study Premium Jul 22, 2020 Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.